Frontiers in Immunology
Second Primary Malignancies After CAR T-Cell Therapy: Causal Attribution, Clonal Evolution, and Risk-Adapted Surveillance
Accepted, not yet published: reviewBlood and immune system
Papers on T-cell malignancy
2 papers1 new in 30 days